LEADER 02734nam 2200613 a 450 001 9910778368903321 005 20230721031928.0 010 $a0-19-168755-3 010 $a1-281-16006-7 010 $a9786611160067 010 $a0-19-152328-3 010 $a1-4356-2072-0 035 $a(CKB)1000000000482015 035 $a(EBL)415267 035 $a(OCoLC)437093369 035 $a(SSID)ssj0000145145 035 $a(PQKBManifestationID)11150668 035 $a(PQKBTitleCode)TC0000145145 035 $a(PQKBWorkID)10156844 035 $a(PQKB)10579694 035 $a(Au-PeEL)EBL415267 035 $a(CaPaEBR)ebr10219920 035 $a(CaONFJC)MIL116006 035 $a(MiAaPQ)EBC415267 035 $a(EXLCZ)991000000000482015 100 $a20070308d2007 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 10$aElectron dynamics by inelastic X-ray scattering$b[electronic resource] /$fWinfried Schu?lke 210 $aOxford ;$aNew York $cOxford University Press$d2007 215 $a1 online resource (606 p.) 225 1 $aOxford series on synchrotron radiation ;$v7 300 $aDescription based upon print version of record. 311 $a0-19-851017-9 320 $aIncludes bibliographical references and index. 327 $aContents; List of important symbols; 1 Introductory survey; 2 Characteristic valence electron excitations; 3 Core-electron excitation (X-ray Raman scattering (XRS)); 4 The Compton scattering regime; 5 Resonant inelastic X-ray scattering (RIXS); 6 Theoretical foundation; Index 330 $aThe book offers the first comprehensive review of experimental methods, theory, and successful applications of synchrotron radiation based inelastic X-ray scattering (IXS) spectroscopy, which enables the investigation of electron dynamics in condensed matter (correlated motion and excitation). - ;Knowledge of the dynamics of many-electron systems is of fundamental importance to all disciplines of condensed matter physics. A very effective access to electron dynamics is offered by inelastic X-ray scattering (IXS) spectroscopy. The double differential scattering cross section for IXS is directly 410 0$aOxford series on synchrotron radiation ;$v7. 606 $aX-rays$xScattering 606 $aElectrons$xInelastic scattering 615 0$aX-rays$xScattering. 615 0$aElectrons$xInelastic scattering. 676 $a539.7/58 700 $aSchu?lke$b Winfried$01577504 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910778368903321 996 $aElectron dynamics by inelastic X-ray scattering$93856133 997 $aUNINA LEADER 03092nam 22006615 450 001 9910300190803321 005 20251117080108.0 010 $a1-907673-76-8 024 7 $a10.1007/978-1-907673-76-4 035 $a(CKB)3710000000280765 035 $a(EBL)1965086 035 $a(OCoLC)908083154 035 $a(SSID)ssj0001386383 035 $a(PQKBManifestationID)11814649 035 $a(PQKBTitleCode)TC0001386383 035 $a(PQKBWorkID)11374306 035 $a(PQKB)11089443 035 $a(DE-He213)978-1-907673-76-4 035 $a(MiAaPQ)EBC1965086 035 $a(PPN)183086295 035 $a(EXLCZ)993710000000280765 100 $a20141112d2015 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aCancer-Related Fatigue /$fby Joachim Weis, Markus Horneber 205 $a1st ed. 2015. 210 1$aTarporley :$cSpringer Healthcare Ltd. :$cImprint: Springer Healthcare,$d2015. 215 $aVII, 74 s 300 $aDescription based upon print version of record. 311 08$a9781907673764 311 08$a1-907673-75-X 320 $aIncludes bibliographical references at the end of each chapters. 327 $aIntroduction -- Etiology and pathogenetic factors -- Nonpharmacological treatment of cancer-related fatigue -- Pharmacological treatment of cancer-related fatigue -- Recommendations for the management of cancer-related fatigue. 330 $aCancer-related fatigue (CrF) is increasingly recognized as a signi?cant problem for patients with cancer at all stages, including those undergoing therapy and in remission. In fact, studies have shown that CrF causes patients more distress than pain, nausea, or vomiting and yet fatigue is still often undertreated and rarely studied. However, several new treatments such as are being investigated to determine the most effective ways to manage this debilitating symptom and improve patient quality of life. Cancer-Related Fatigue will provide a concise overview of this condition, with an evidence-based discussion of diagnosis, treatment, and long-term management. 606 $aMedicine 606 $aOncology 606 $aInternal medicine 606 $aMedicine/Public Health, general$3https://scigraph.springernature.com/ontologies/product-market-codes/H00007 606 $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160 606 $aInternal Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/H33002 615 0$aMedicine. 615 0$aOncology. 615 0$aInternal medicine. 615 14$aMedicine/Public Health, general. 615 24$aOncology. 615 24$aInternal Medicine. 676 $a610 676 $a616 676 $a616994 700 $aWeis$b Joachim$4aut$4http://id.loc.gov/vocabulary/relators/aut$0789319 702 $aHorneber$b Markus$4aut$4http://id.loc.gov/vocabulary/relators/aut 906 $aBOOK 912 $a9910300190803321 996 $aCancer-Related Fatigue$92522511 997 $aUNINA